8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                             ----------------------

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

      Date of Report (Date of the earliest event reported): April 14, 2006

                                  Aspyra, Inc.
             (Exact Name of Registrant as Specified in Its Charter)

          California                  0-12551                    95-3353465
(State or Other Jurisdiction        (Commission                (IRS Employer
       of Incorporation)            File Number)             Identification No.)

                               26115-A Mureau Road
                               Calabasas, CA 91302
               (Address of Principal Executive Offices) (Zip Code)

                                 (818) 880-6700
              (Registrant's Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

|_|  Written communications pursuant to Rule 425 under the Securities
     Act (17 CFR 230.425)

|_|  Soliciting material pursuant to Rule 14a-12 under the Exchange
     Act (17 CFR 240.14a-12)

|_|  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

|_|  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))



                                      -1-



Item 7.01    Regulation FD Disclosure.

     On April 14, 2006, Aspyra, Inc. issued a press release announcing its
operating and financial results for the fourth quarter and fiscal year ended
December 31, 2005. A copy of the Press Release is attached hereto as Exhibit
99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

     The information furnished under this Item 7.01 ("Regulation FD Disclosure")
is intended to be furnished under Item 2.02 ("Results of Operations and
Financial Condition"). The information in this Current Report on Form 8-K and
the Exhibit attached hereto, shall not be deemed to be "filed" for the purposes
of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that section, nor shall such information be deemed
incorporated by reference in any filing under the Securities Act of 1933, as
amended, except as shall be expressly set forth by specific release in such a
filing.

     Except for historical information contained in the press release attached
as an exhibit hereto, the press release contains forward-looking statements,
which involve certain risks and uncertainties that could cause actual results to
differ materially from those expressed or implied by these statements. Please
refer to the cautionary note in the press release regarding these
forward-looking statements..


Item 9.01    Financial Statements and Exhibits.

       (c) Exhibits.

The following exhibit is filed as part of this Current Report on Form 8-K:


Exhibit No.              Description of Exhibit
- ---------------------    -------------------------------------------------------

99.1                     Aspyra, Inc. Press Release, issued April 14, 2006.



                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


April 14, 2006                        Aspyra, Inc.

                                         /S/ Steven M. Besbeck
                                      ------------------------------------------
                                         Steven M. Besbeck
                                         President and Chief Executive Officer



                                      -2-




                                  EXHIBIT INDEX

     Exhibit
Exhibit No.              Description of Exhibit
- ---------------------    -------------------------------------------------------

99.1                     Aspyra, Inc. Press Release, issued April 14, 2006.




                                      -3-

EX-99.1

                                                                    Exhibit 99.1

             Aspyra, Inc. (AMEX - APY) Reports Results of
             Operations for the Fourth Quarter and Fiscal
                     Year Ended December 31, 2005

    CALABASAS, Calif.--(BUSINESS WIRE)--April 14, 2006--Aspyra, Inc.
(AMEX:APY) ... a provider of clinical and diagnostic information
systems for the healthcare industry, today reported its results of
operations for the fourth quarter and fiscal year ended December 31,
2005.
    Sales were $2,096,790 for the fourth quarter and the company
incurred a net loss of $1,003,261 or basic and diluted net loss per
share of $.17 and $.16 respectively. For the fiscal year sales were
$7,205,757 and the company incurred a net loss of $2,501,915 or basic
and diluted net loss per share of $.62, including an adjustment of
$793,877 to fully reserve the deferred tax asset.
    Steven M. Besbeck stated, "The results of operations were for the
first reporting period since the consummation of the merger between
the company and StorCOMM, Inc. on November 22, 2005. The reported
periods only included operations for StorCOMM for one month and eight
days in accordance with GAAP accounting standards. The results of
operation for the period should not be viewed as an indication of the
results to be expected for any future period. For more complete
information please review the Company's annual report on Form 10KSB.
We are making progress on integrating the businesses and we have begun
to market our new integrated RIS/PACS product AccessRAD(TM) which is
the result of significant development efforts. We look forward to
improved operating results later this year."
    Aspyra is a global provider of clinical and diagnostic information
solutions for the healthcare industry. We have accumulated over 35
years of industry experience, specializing in enterprise-wide systems
for hospitals, multi-specialty clinics, clinical laboratories, imaging
departments and centers, orthopedic environments and pharmacies. Our
highly scalable products may be installed as standalone or integrated
to provide a single-vendor solution. For more information on Aspyra,
its products and services, visit www.aspyra.com

    Safe Harbor Statement

    This press release includes forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including statements related to anticipated revenues, expenses,
earnings, operating cash flows, the outlook for Aspyra's markets and
the demand for its products. Forward-looking statements are not
guarantees of future performance and are inherently subject to
uncertainties and other factors which could cause actual results to
differ materially from the forward-looking statement. Such statements
are based upon, among other things, assumptions made by, and
information currently available to, management as of today April 14,
2006, including management's own knowledge and assessment of the
Company's industry and competition. Factors that could cause Aspyra's
actual results to differ materially from these forward-looking
statements include among others: whether the combined company will
realize the potential benefits of the merger; the competitive
environment; unexpected technical and marketing difficulties inherent
in major product development efforts; the potential need for changes
in our long-term strategy in response to future developments; future
advances in clinical information technology and procedures, as well as
potential changes in government regulations and healthcare policies;
and rapid technological change in the microelectronics and software
industries. The Company refers interested persons to its most recent
Annual Report on Form 10-KSB and its other SEC filings for a
description of additional uncertainties and factors, which may affect
forward-looking statements. The Company assumes no duty to update its
forward-looking statements.



    CONTACT: Aspyra, Inc.
             Steven M. Besbeck, 818-880-6700 x252